These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20068351)

  • 1. Increased risk of chronic kidney disease in elderly with metabolic syndrome and high levels of C-reactive protein: Kahrizak Elderly Study.
    Fakhrzadeh H; Ghaderpanahi M; Sharifi F; Badamchizade Z; Mirarefin M; Larijani B
    Kidney Blood Press Res; 2009; 32(6):457-63. PubMed ID: 20068351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults.
    Lee JE; Choi SY; Huh W; Kim YG; Kim DJ; Oh HY
    Am J Hypertens; 2007 Nov; 20(11):1189-94. PubMed ID: 17954366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
    Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C
    Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome.
    Santos AC; Lopes C; Guimarães JT; Barros H
    Int J Obes (Lond); 2005 Dec; 29(12):1452-6. PubMed ID: 16077717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the metabolic syndrome and chronic kidney disease in Chinese adults.
    Chen J; Gu D; Chen CS; Wu X; Hamm LL; Muntner P; Batuman V; Lee CH; Whelton PK; He J
    Nephrol Dial Transplant; 2007 Apr; 22(4):1100-6. PubMed ID: 17272313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women.
    Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R
    Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
    Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
    Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
    Whaley-Connell A; Sowers JR; McCullough PA; Roberts T; McFarlane SI; Chen SC; Li S; Wang C; Collins AJ; Bakris GL;
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S11-21. PubMed ID: 19285607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of metabolic syndrome with inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III).
    Beddhu S; Kimmel PL; Ramkumar N; Cheung AK
    Am J Kidney Dis; 2005 Oct; 46(4):577-86. PubMed ID: 16183411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and metabolic syndrome-related chronic kidney disease in nondiabetic, nonhypertensive adults.
    Yoon YS; Park HS; Yun KE; Kim SB
    Metabolism; 2009 Dec; 58(12):1737-42. PubMed ID: 19615700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and its relation to chronic kidney disease in a Southeast Asian population.
    Satirapoj B; Supasyndh O; Mayteedol N; Chaiprasert A; Choovichian P
    Southeast Asian J Trop Med Public Health; 2011 Jan; 42(1):176-83. PubMed ID: 21323181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study.
    Martínez MA; Puig JG; Mora M; Aragón R; O'Dogherty P; Antón JL; Sánchez-Villares T; Rubio JM; Rosado J; Torres R; Marcos J; Pallardo LF; Banegas JR;
    Metabolism; 2008 Sep; 57(9):1232-40. PubMed ID: 18702949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic risk factors associated with erosive esophagitis.
    Chua CS; Lin YM; Yu FC; Hsu YH; Chen JH; Yang KC; Shih CH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1375-9. PubMed ID: 19467140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.
    Ryu S; Chang Y; Woo HY; Lee KB; Kim SG; Kim DI; Kim WS; Suh BS; Jeong C; Yoon K
    Am J Kidney Dis; 2009 Jan; 53(1):59-69. PubMed ID: 18838200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study.
    Lucove J; Vupputuri S; Heiss G; North K; Russell M
    Am J Kidney Dis; 2008 Jan; 51(1):21-8. PubMed ID: 18155529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
    Misra KB; Endemann SW; Ayer M
    Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of chronic kidney disease in La Réunion island and its association with the metabolic syndrome in the non-diabetic population: La Réunion Diabetes (REDIA) Study.
    Stengel B; Jaussent I; Guiserix J; Bourgeon B; Papoz L; Favier F;
    Diabetes Metab; 2007 Dec; 33(6):444-52. PubMed ID: 18006351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome is not a risk factor for kidney dysfunction in obese non-diabetic subjects.
    Gatti A; Morini E; De Cosmo S; Maiani F; Mandosi E; Fallarino M; Morano S; Trischitta V
    Obesity (Silver Spring); 2008 Apr; 16(4):899-901. PubMed ID: 18239564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.